Question from Deputy Richard Boyd Barrett - PQ 28467-26
Deputy Boyd Barrett asked about the plans in place to ensure that PET-CT scanners are available in every public hospital providing cancer treatment service.
- Published date:
- :
Corporate publications
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Showing 2921 to 2930 of 8895 results
Question from Deputy Ken O'Flynn - PQ 28640-26
Deputy O'Flynn asked about any formal public health guidance or advisories in relation to manganese exposure in drinking water. Read the HSE response.
- Published date:
- :
Question from Deputy Ken O'Flynn - PQ 28067-26
Deputy O'Flynn asked about mechanisms that are in place to monitor rejection rates for commonly prescribed medicines. Read the HSE response.
- Published date:
- :
Question from Deputy Ken O'Flynn - PQ 28068-26
Deputy O'Flynn asked about any audit or validation exercise has been conducted on the accuracy/consistency of claim rejections by PCRS. Read the HSE response.
- Published date:
- :
Question from Deputy Ken O'Flynn - PQ 28039-26
Deputy O'Flynn asked about alerts to identify significant increases in spend on specific medicines, including salbutamol nebules. Read the HSE response.
- Published date:
- :
Question from Deputy Ken O'Flynn - PQ 28041-26
Deputy O'Flynn asked about whether benchmarking has been carried out comparing expenditure and utilisation of salbutamol nebules. Read the HSE response.
- Published date:
- :
Question from Deputy Ken O'Flynn - PQ 28038-26
Deputy O'Flynn asked about any audit review conducted in respect of expenditure on salbutamol nebules under PCRS since 2024. Read the HSE response.
- Published date:
- :
Question from Deputy Ken O'Flynn - PQ 28064-26
Deputy O'Flynn asked if PCRS maintains product-specific data on rejected or unpaid pharmacy claims. Read the HSE response.
- Published date:
- :
Question from Deputy Ken O'Flynn - PQ 28034-26
Deputy O'Flynn asked about the reimbursement price per unit applicable to salbutamol nebules under PCRS 2024-2026. Read the HSE response.
- Published date:
- :
Question from Deputy Ken O'Flynn - PQ 28036-26
Deputy O'Flynn asked why the PCRS does not capture or retain data on the clinical indication associated with medicines reimbursed. Read the HSE response.
- Published date:
- :